In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Albert H. C. Wong
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Albert H. C. Wong

First Name:Albert H. C.
Last Name:Wong
Advanced Degrees:MD PhD
Affiliation:University of Toronto
Street Address 1:Centre for Addiction and Mental Health
Street Address 2:250 College Street, Room 711
Zip/Postal Code:M5T 1R8
Email Address:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 20 January 2007]
View all comments by Albert H. C. Wong
Clinical Interests:
Schizophrenia, Neurodevelopmental disorders (e.g., 22q11 deletion syndromes)
Research Focus:
DNA microrrays, Phenomenology/diagnosis, Molecular and Cell biology, Neurodevelopment, Pharmacology, Genetics, Animal models, Neuroanatomy/Systems Neuroscience
Work Sector(s):
Research institute, University, Medical hospital
Web Sites:
Reasearcher Bio
I am currently a clinician-scientist in the Department of Psychiatry at the University of Toronto. My main interest is in using animal models to identify molecular pathways that regulate behavioural dimensions relevant to psychotic disorders.
Top Papers
Semeralul MO, Boutros PC, Likhodi O, Okey AB, Van Tol HHM, Wong AHC: Microarray analysis of the developing cortex, J. Neurobiology 2006 Dec;66(14):1646-58

Wong AHC, Gottesman I, Petronis A: Phenotypic differences in genetically identical organisms: the epigenetic perspective, Human Molecular Genetics 2005; 14(R1): R11-18

Wong AHC, Lipska BK, Likhodi O, Boffa E, Weinberger DR, Kennedy JL, Van Tol HHM: Cortical gene expression in the neonatal ventral hippocampal lesion rat model, Schizophrenia Research 2005; 77(2-3):261-27

Wong AHC, Trakalo J, Likhodi O, Yusuf M, Macedo A, Azevedo M-H, Klempan T, Pato MT, Honer WG, Pato CN, Van Tol HHM, Kennedy JL: Association between schizophrenia and the syntaxin 1a gene, Biological Psychiatry 2004; 56(1):24-29

Wong AHC, et al: Identification of candidate genes for psychosis in rat models and possible association between schizophrenia and the 14-3-3eta gene. Molecular Psychiatry 2003; 8(2): 156-166
What are the top three papers (not yours) you have read recently?
Hovatta I et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.
Nature. 2005 Dec 1;438(7068):662-6

Levenson JM et al. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem. 2006 Jun9;281(23): 15763-73

Meyer U et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci. 2006 May 3;26(18):4752-62
If resources were not limited, what research projects would you pursue?
Comprehensive correlational screens of behavioural phenotype, genetic sequencing, transciptome and proteome in a battery of mouse, rat and primate models.
What is your leading hypothesis?
There are symptom dimensions and endophenotypes that are under both genetic and epigenetic control. These interacting dimensional variables (e.g. sensory gating, susceptibility to erroneous causal inferences or working memory) combine to create clinical syndromes. Specifying the molecular regulation of these dimensions will permit development of targeted interventions for each, that will be used in combinations tailored to each patient.
What piece of missing evidence would help prove it?
There is no single piece of evidence, but a gradual accumlation of knowledge about these specific dimensions, coming from a wide range of methods: genetics, molecular and cell biology, animal behaviour models and clinical studies.
What is your fallback position?
That some traditional diagnostic categories do exist as discrete disease entities with heterogeneous causes.

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright